Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Inventory Average (2016 - 2026)

Myriad Genetics has reported Inventory Average over the past 15 years, most recently at $31.1 million for Q4 2025.

  • Quarterly Inventory Average rose 15.83% to $31.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.1 million through Dec 2025, up 15.83% year-over-year, with the annual reading at $29.0 million for FY2025, 17.37% up from the prior year.
  • Inventory Average was $31.1 million for Q4 2025 at Myriad Genetics, up from $30.2 million in the prior quarter.
  • Over five years, Inventory Average peaked at $31.1 million in Q4 2025 and troughed at $15.4 million in Q1 2022.
  • The 5-year median for Inventory Average is $23.4 million (2023), against an average of $23.0 million.
  • Year-over-year, Inventory Average crashed 40.23% in 2022 and then surged 42.9% in 2023.
  • A 5-year view of Inventory Average shows it stood at $17.0 million in 2021, then grew by 17.11% to $19.8 million in 2022, then grew by 18.64% to $23.6 million in 2023, then grew by 14.01% to $26.8 million in 2024, then rose by 15.83% to $31.1 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Inventory Average are $31.1 million (Q4 2025), $30.2 million (Q3 2025), and $28.5 million (Q2 2025).